This work assessed the feasibility of quantitative parameters derived from APT and IVIM in the predicting the recurrence of early stage Hepatocellular carcinoma (HCC) treated with transcatheter arterial chemoembolization (TACE). We find that combined quantitative parameters of APT and IVIM can be used to predict the recurrence. Therefore, APT and IVIM can be used as imaging biomarkers to predict the recurrence of early stage of HCC after TACE treatment.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords